119 related articles for article (PubMed ID: 28566248)
1. [Prognostic factors for head and neck cancer reirradiation: A systematic review].
Ohnleiter T; Truntzer P; Antoni D; Guihard S; Elgard AM; Noël G
Cancer Radiother; 2017 Jun; 21(4):316-338. PubMed ID: 28566248
[TBL] [Abstract][Full Text] [Related]
2. Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors.
Buglione M; Maddalo M; Mazzeo E; Bonomo P; Spiazzi L; Bruni A; Paiar F; Triggiani L; Greto D; Rubino L; Livi L; Bertoni F; Magrini SM
Tumori; 2015; 101(5):585-92. PubMed ID: 26108237
[TBL] [Abstract][Full Text] [Related]
3. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
[TBL] [Abstract][Full Text] [Related]
4. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
5. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity.
Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581
[TBL] [Abstract][Full Text] [Related]
6. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.
Phan J; Sio TT; Nguyen TP; Takiar V; Gunn GB; Garden AS; Rosenthal DI; Fuller CD; Morrison WH; Beadle B; Ma D; Zafereo ME; Hutcheson KA; Kupferman ME; William WN; Frank SJ
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):30-41. PubMed ID: 27325480
[TBL] [Abstract][Full Text] [Related]
7. [Reirradiation of head and neck cancers].
Doyen J; Lam Cham Kee D; Krebs L; Guigay J; Dassonville O; Peyrade F; Poissonnet G; Saâda-Bouzid E; Sudaka A; Bozec A; Bénézery K
Cancer Radiother; 2017 Oct; 21(6-7):521-526. PubMed ID: 28826697
[TBL] [Abstract][Full Text] [Related]
8. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in patients with recurrent head and neck cancer treated with reirradiation.
Krstevska V; Tolevska C; Zafirova-Ivanova B; Stojkovski I; Crvenkova S
J BUON; 2008; 13(3):369-76. PubMed ID: 18979552
[TBL] [Abstract][Full Text] [Related]
10. Reirradiation of head and neck cancer using modern highly conformal techniques.
Ho JC; Phan J
Head Neck; 2018 Sep; 40(9):2078-2093. PubMed ID: 29684256
[TBL] [Abstract][Full Text] [Related]
11. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
[TBL] [Abstract][Full Text] [Related]
12. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
Kramer NM; Horwitz EM; Cheng J; Ridge JA; Feigenberg SJ; Cohen RB; Nicolaou N; Sherman EJ; Babb JS; Damsker JA; Langer CJ
Head Neck; 2005 May; 27(5):406-14. PubMed ID: 15719391
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
[TBL] [Abstract][Full Text] [Related]
14. [Reirradiation for head and neck squamous cell carcinoma: Indications and results].
Biau J; Moreau J; Blanchard P; Thariat J; Miroir J; Lapeyre M
Cancer Radiother; 2019 Oct; 23(6-7):559-564. PubMed ID: 31451359
[TBL] [Abstract][Full Text] [Related]
15. Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review.
Kao J; Garofalo MC; Milano MT; Chmura SJ; Citron JR; Haraf DJ
Cancer Treat Rev; 2003 Feb; 29(1):21-30. PubMed ID: 12633577
[TBL] [Abstract][Full Text] [Related]
16. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
Watkins JM; Shirai KS; Wahlquist AE; Stuart RK; Chaudhary UB; Garrett-Mayer E; Day TA; Gillespie MB; Sharma AK
Head Neck; 2009 Apr; 31(4):493-502. PubMed ID: 19156831
[TBL] [Abstract][Full Text] [Related]
17. Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer.
Yamazaki H; Ogita M; Himei K; Nakamura S; Suzuki G; Yoshida K; Kotsuma T; Yoshioka Y
J Radiat Res; 2016 Jun; 57(3):288-93. PubMed ID: 26983982
[TBL] [Abstract][Full Text] [Related]
18. Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial.
Hehr T; Classen J; Belka C; Welz S; Schäfer J; Koitschev A; Bamberg M; Budach W
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1423-31. PubMed ID: 15817346
[TBL] [Abstract][Full Text] [Related]
19. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Choe KS; Haraf DJ; Solanki A; Cohen EE; Seiwert TY; Stenson KM; Blair EA; Portugal L; Villaflor VM; Witt ME; Vokes EE; Salama JK
Cancer; 2011 Oct; 117(20):4671-8. PubMed ID: 21671479
[TBL] [Abstract][Full Text] [Related]
20. Postoperative reirradiation for mucosal head and neck squamous cell carcinomas.
Iseli TA; Iseli CE; Rosenthal EL; Caudell JJ; Spencer SA; Magnuson JS; Smith AN; Carroll WR
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1158-64. PubMed ID: 19917931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
